Search results
AbbVie inks immune disorder drug licensing deal with China's FutureGen
AOL· 13 hours agoAbbVie has been counting on its newer immunology medicines to help make up for declining sales of blockbuster arthritis drug Humira following the entry of biosimilars in the U.S. The drugmaker ...
Agenus (NASDAQ:AGEN) Stock Crosses Above 200-Day Moving Average of $12.95
ETF DAILY NEWS· 3 days agoAgenus Inc. (NASDAQ:AGEN – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $12.95 and traded as high as $17.65.
Ultragenyx (RARE) Posts New Data From Bone Disease Study
Zacks via Yahoo Finance· 2 days agoUltragenyx's (RARE) pipeline candidate setrusumab shows sustained reductions in fracture rates in...
Dr. Jeff Hersh addresses cause, effects and complications of Graft vs Host Disease
The Metrowest Daily News via Yahoo News· 6 days agoGraft vs Host Disease occurs when white blood cells produced by donated stem cells identify the...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
WKBT La Crosse· 3 days agoDonanemab works by helping the body remove amyloid plaque buildups in the brain that are a hallmark...
Inebilizumab 'MITIGATES' Flare Risk in IgG4-Related Disease
Medscape· 7 days agoInebilizumab-cdon reduced the risk for flares by 87% in patients with IgG4-RD, the MITIGATE study showed.
Dianthus Therapeutics, Inc. (NASDAQ:DNTH) Forecasted to Post Q2 2024 Earnings of ($0.58) Per Share
ETF DAILY NEWS· 21 hours agoDianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Equities researchers at Lifesci Capital...
Phase 2 Study Shows Opdivo-Yervoy Highly Effective In Colon Cancer
Forbes· 7 days agoA four-week course of dual immunotherapy prior to surgery is highly effective in treating a certain...
FDA clears Dianthus Therapeutics' Phase 2 MMN drug trial By Investing.com
Investing.com· 2 days agoDianthus Therapeutics, Inc. (NASDAQ:DNTH), a biotech firm, has received FDA clearance for a Phase 2...
Opinion: San Diego's life sciences industry has long history of historic breakthroughs
U-T San Diego· 2 days agoPanetta is president and chief executive officer at Biocom California and lives in San Diego. Guerra...